Search research articles
Contact Us
Filters
Showing results (81-90 of 137) with videos related to
Page
of 14
Sort By:
Lancet (London, England)
|
August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Muthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.
Journal of the American College of Cardiology
|
March 18, 2026
Comparative Prognosis of Chagas and Other Cardiomyopathies
Ryohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.
Molecular Imaging and Biology
|
April 16, 2026
Prospective Pilot Study of <sup>11</sup>C-acetate and <sup>18</sup>F-FDG with PET/CT and PET/MRI for Lesion Detection in Multiple Myeloma
Kristina Yancey, Will Han, Ming Yang, et al.
Journal of Nuclear Medicine Technology
|
February 10, 2026
PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape
Ty Skyles, Samantha M Bouchal, Anna Giarratana, et al.
European Journal of Heart Failure
|
May 29, 2021
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
Scott D Solomon, Rudolf A de Boer, David DeMets, et al.
Circulation. Heart Failure
|
November 17, 2017
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy
Li Shen, Felix Ramires, Felipe Martinez, et al.
Nature Medicine
|
October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction
Muthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.
Journal of the American College of Cardiology
|
March 19, 2016
Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial
Renato D Lopes, Sergio Leonardi, Benjamin Neely, et al.
Journal of the American College of Cardiology
|
August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure
Muthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
American Heart Journal
|
September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
Jose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 137) with videos related to
Sort By:
Page
of 14
Lancet (London, England)
|
August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Muthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.
Journal of the American College of Cardiology
|
March 18, 2026
Comparative Prognosis of Chagas and Other Cardiomyopathies
Ryohei Ono, Kieran F Docherty, Alasdair D Henderson, et al.
Molecular Imaging and Biology
|
April 16, 2026
Prospective Pilot Study of <sup>11</sup>C-acetate and <sup>18</sup>F-FDG with PET/CT and PET/MRI for Lesion Detection in Multiple Myeloma
Kristina Yancey, Will Han, Ming Yang, et al.
Journal of Nuclear Medicine Technology
|
February 10, 2026
PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape
Ty Skyles, Samantha M Bouchal, Anna Giarratana, et al.
European Journal of Heart Failure
|
May 29, 2021
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
Scott D Solomon, Rudolf A de Boer, David DeMets, et al.
Circulation. Heart Failure
|
November 17, 2017
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy
Li Shen, Felix Ramires, Felipe Martinez, et al.
Nature Medicine
|
October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction
Muthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.
Journal of the American College of Cardiology
|
March 19, 2016
Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial
Renato D Lopes, Sergio Leonardi, Benjamin Neely, et al.
Journal of the American College of Cardiology
|
August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure
Muthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
American Heart Journal
|
September 21, 2015
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
Jose Carlos Nicolau, Deepak L Bhatt, Matthew T Roe, et al.
Page
of 14